Davide Franceschini
Overview
Explore the profile of Davide Franceschini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
1544
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marzo A, Cozzi L, Franceschini D, Dominici L, Spoto R, Laurelli F, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858075
Background: Radiotherapy for thymoma is delivered post-operatively in selected cases. Given the particular location of the thymic bed and the excellent prognosis, late cardiac toxicities may be an issue. The...
2.
Gori S, De Rose F, Ferro A, Fabi A, Angiolini C, Azzarello G, et al.
Cancer Treat Rev
. 2024 Oct;
131:102832.
PMID: 39437511
Breast cancer stands as the most frequently diagnosed cancer and the primary cause of cancer-related mortality among women worldwide, including Italy. With the increasing number of survivors, many are enrolled...
3.
Franzese C, Vernier V, Badalamenti M, Lucchini R, Stefanini S, Bertolini A, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272821
Background: Stereotactic ablative radiotherapy (SABR) is emerging as a potential local treatment option for oligometastatic RCC. This study aims to evaluate the efficacy of SABR in patients with oligorecurrent RCC....
4.
Nardone V, Bruni A, Franceschini D, Marini B, Vagge S, Ciammella P, et al.
Radiol Med
. 2024 Aug;
129(11):1700-1709.
PMID: 39215945
Background: Recently, the PORT-C and LUNG-ART trials, which evaluated the role of postoperative radiation therapy (PORT), have significantly altered the treatment landscape for NSCLC pN2 patients who previously underwent surgery....
5.
Franceschini D, Loi M, Marzo A, Dominici L, Spoto R, Bertolini A, et al.
Diseases
. 2024 Jul;
12(7).
PMID: 39057124
Few data are available on the role of SBRT re-irradiation for isolated recurrences. We designed a prospective phase I study to evaluate the maximum tolerated dose (MTD) of SBRT for...
6.
Ghirardelli P, Costantino G, Franceschini D, Villa E, Guaineri A, Scorsetti M, et al.
Pract Radiat Oncol
. 2024 May;
14(6):e487-e491.
PMID: 38815652
There is growing evidence of a role of stereotactic body radiation therapy (SBRT) in the treatment of patients with oligoprogressive pleural mesothelioma (PM). The objective of this study was to...
7.
Rossi S, Pagliaro A, Michelini A, Navarria P, Clerici E, Franceschini D, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136306
Small-cell lung cancer is an extremely chemo-sensitive disease; the addition of immunotherapy to chemotherapy has demonstrated a slight clinical benefit in pivotal trials, even with a statistically significant difference in...
8.
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort
Borghetti P, Facheris G, Ciammella P, Galaverni M, Granello L, Scotti V, et al.
Clin Lung Cancer
. 2023 Dec;
25(2):151-158.
PMID: 38052684
Aims: SCLC is the most aggressive lung cancer histology with a 5-year OS <10%. At the diagnosis, almost two-thirds of the SCLC an Extended Disease presentation. Two randomized studies (CASPIAN...
9.
Marvaso G, Mastroleo F, Corrao G, Zaffaroni M, Vincini M, Borghetti P, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568718
The term "oligometastasis" represents a relatively novel idea, which denotes a condition characterized by cancer dissemination with a limited number of lesions (usually fewer than five). The aim of the...
10.
Comito T, Massaro M, Teriaca M, Franzese C, Franceschini D, Navarria P, et al.
Curr Oncol
. 2023 Jul;
30(7):7073-7088.
PMID: 37504373
Aim: The gold standard of care for pancreatic adenocarcinoma is the integrated treatment of surgery and chemotherapy (ChT), but about 50% of patients present with unresectable disease. Our study evaluated...